Gastritis Clinical Trial
Official title:
A Multi-Center, Randomized, Parallel, Double-Blind, Phase III Clinical Trial to Compare the Efficacy and Safety of DWC20155/DWC20156 Combination Therapy With DWC20155 or DWC20156 Monotherapy in Patients With Gastritis
| Verified date | June 2019 |
| Source | Daewoong Pharmaceutical Co. LTD. |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
THe purpose of this study is to evaludate the Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients with Gastritis
| Status | Terminated |
| Enrollment | 230 |
| Est. completion date | May 17, 2018 |
| Est. primary completion date | May 17, 2018 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 19 Years and older |
| Eligibility |
Inclusion Criteria: - Male of female of at least 19 years old - Patients diagnosed with acute or chronic gastritis by gastroscopy - Patients with one or more erosions found by gastroscopy Exclusion Criteria: - Patients with peptic ulcer and gastroesophageal reflux disease - Patients with previous gastrointestinal surgery - Patients with history of gastrointestinal cancer |
| Country | Name | City | State |
|---|---|---|---|
| Korea, Republic of | Daewoong pharmatceutical | Seoul |
| Lead Sponsor | Collaborator |
|---|---|
| Daewoong Pharmaceutical Co. LTD. |
Korea, Republic of,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Improvement rates of stomach erosions by the endoscopy | At 2 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04289519 -
Endoscopic Findings of Gastritis in Children
|
||
| Recruiting |
NCT02353039 -
Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
|
Phase 2 | |
| Recruiting |
NCT05545397 -
Sedation Level on Machine Learning With Electroencephalogram in Painless Gastroenteroscopy Patients
|
||
| Not yet recruiting |
NCT05510388 -
HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients
|
N/A | |
| Completed |
NCT02724280 -
Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy
|
N/A | |
| Not yet recruiting |
NCT02961296 -
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
|
N/A | |
| Completed |
NCT02385045 -
i-Scan for the Detection of Helicobacter Pylori
|
N/A | |
| Completed |
NCT00212225 -
Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)
|
N/A | |
| Completed |
NCT04672018 -
Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis
|
Phase 2 | |
| Not yet recruiting |
NCT05072938 -
Phase IV Clinical Trial to Compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
|
Phase 4 | |
| Completed |
NCT02597517 -
New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy
|
N/A | |
| Completed |
NCT02296021 -
Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy
|
Phase 4 | |
| Completed |
NCT01576289 -
Analysis of Biopsies From the Upper Gastrointestinal Tract
|
N/A | |
| Active, not recruiting |
NCT03509831 -
[KJ-INT-002] BE Study
|
Phase 1 | |
| Terminated |
NCT05579444 -
Systems Biology of Gastrointestinal and Related Diseases
|
||
| Suspended |
NCT04306939 -
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
|
||
| Completed |
NCT05237115 -
Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy
|
Phase 4 | |
| Completed |
NCT02393430 -
Clinical Effect of Rebamipide on Chronic Gastritis
|
Phase 4 | |
| Completed |
NCT00579410 -
Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
|
N/A | |
| Completed |
NCT00267475 -
Data Bank for Eosinophilic Disorders
|
N/A |